In 2018, COS celebrated its 5th anniversary, this year, we are thrilled to announce the launch of Oncology Outcomes: Strategic Advisory Partnership. This oncology-focused research partnership led by Stacie Hudgens is launched in collaboration with global thought-leader, Alicyn Campbell. This innovative partnership will expand the resources and expertise available to our clients, further strengthening COS’s position at the forefront of …
Article from Senior Director, Clinical Outcome Assessments, Louise Newton MSc. The use of patient-reported outcome (PRO) measures in clinical practice is increasing. Following the creation of a ‘User’s Guide to Implementing PRO Assessment in Clinical Practice’ by the International Society for Quality of Life Research (ISOQOL), volunteers from ISOQOL sought to create a Companion Guide to assist health care providers …
Recent presentations at ISPOR EU Barcelona as follows: Crawford B, Kim HR, Newton L, Symonds T. Roadblocks and resolutions: development of PRO instruments for multinational trials (Workshop 1). Presentation date: 12 November 2018; 11:15–12:15 Hudgens S, Newton L, Eremenco S, Crescioni M, Symonds T, Griffiths P,Knight-West O, Reasner DS, Byrom B, O’Donohoe P, Vallow S. Comparability of a provisioned device …
We are excited to announce that Louise Newton’s article, “A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective.” published in Journal of Patient-Reported Outcomes in 2017, has been awarded the ISOQOL Outstanding Article of the Year Award. The award recognizes and honors the single best article dedicated to health-related quality of …
Stacie Hudgens, Chief Executive Officer, Strategic Lead Regulatory and Access, at COS, has an article published in Liver International: ‘Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C’ To view this article, please click here. To find out more about Stacie Hudgens, please click here.
Stacie Hudgens MSc, Chief Executive Officer, Strategic Lead Regulatory and Access, has a manuscript published in The Lancet this month, entitled ‘Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial’. This is a paper focused on understanding health-related quality of life in an ovarian maintenance …
Stacie Hudgens and Libby Floden from Clinical Outcomes Solutions have two posters selected for Speed presentations at the Joint Statistical Meeting 2018 in Vancouver. To view the presentations click below: Analysis of Multiple Thresholds in a Responder Analysis of Patient-Reported Outcome Measures Single Item Analysis of Patient-Reported Outcome Measures in a Phase III Randomized Controlled Trial
Article from lead author Tara Symonds, Strategic Lead, Clinical Outcomes Assessments Results from this qualitative study were applied to develop the Penn-FPS-R, a brief 12-item outcome measure, with established content validity that can be used to assess the impact of TN pain and treatment outcome in both clinical practice and research. To download the article online, click here To access the …
Members of the COS Team will be presenting at the ISPOR 23rd Annual International Meeting taking place at the Baltimore Convention Centre, Baltimore, Maryland between 19-23rd May 2018. You can download the COS Presentation list here. You can also download the COS ISPOR 23rd Annual International Meeting leaflet here.
The International Society of Quality of Life Research (ISOQOL) recently published their Companion Guide to the User’s Guide for Implementing PRO Measures in Clinical Practice. A small team from ISOQOL’s Clinical Practice Special Interest Group, including Louise Newton (Senior Director of Clinical Outcomes Assessment), led the development of the Companion Guide. The purpose of the Companion Guide is to help …